Blog | Gen Re

Our Perspective

3 Ways to Change How We Talk About Disability Insurance

By Steve Woods |May 05, 2017|English

May is Disability Insurance Awareness Month (DIAM) in the U.S., which means it’s a good time of year to bring consumers’ attention to an often misunderstood and overlooked product. In the spirit of this campaign, I would like to share a...
Read More
Predictive Analytics Global Survey Results - Still Room to Grow for Life & Health Insurers

By Guizhou Hu|April 05, 2017|English | Chinese

How big is “big data” for life and health insurers? What are insurers worldwide focused on when it comes to predictive analytics? How are they adopting it and what are their expectations for the future? We set out to find answers to these...
Read More
Insurers Shouldn’t Stigmatize Epilepsy

By Anke Siebers |February 13, 2017|English | Deutsch

Epilepsy is a neurological disorder that can affect people of all ages. According to the WHO, some 50 million people around the world have epilepsy and an estimated 2.4 million new diagnoses are made each year. The condition has significant implications...
Read More
Keeping Workers Safe From Cancer - Will EU Proposals Cut Cancer Rates?

By Dr. Chris Ball |January 25, 2017|English

Cancer arising from workplace exposure has a long history. The earliest recognised form of occupational cancer in the world is Chimney sweep’s carcinoma, cancer of the skin of the scrotum, first described in England in 1775. In many workplaces...
Read More
Breast Cancer in Asia – A Look at the Incidence Rates and Trends

By Dr. Himanshu Bhatia |November 28, 2016|English

Almost one in four cases of female breast cancer diagnoses around the world are in the Asia-Pacific region – the highest proportion of new cases in China (46%), Japan (14%) and Indonesia (12%). The global total of new cancer cases is projected...
Read More
The Risk of Addiction With Sedative Prescriptions

By Dr. Chris Ball |August 21, 2016|English

In an earlier blog I outlined the health threat and addiction potential from non-prescription use of opioid painkillers. However, the problems do not stop with this class of drug. Sedative and hypnotic drugs also pose significant risk of physical and...
Read More